利润表（华恒生物）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 1,539,034,126.35 | 1,016,220,737.71 | 500,781,373.59 | 1,938,268,117.78 | 1,364,161,262.06 | 849,888,607.49 | 400,254,753.80 |
| 营业收入(元) | 1,539,034,126.35 | 1,016,220,737.71 | 500,781,373.59 | 1,938,268,117.78 | 1,364,161,262.06 | 849,888,607.49 | 400,254,753.80 |
| 二、营业总成本(元) | 1,382,619,720.33 | 870,509,300.90 | 411,603,470.89 | 1,447,706,028.02 | 1,006,806,422.12 | 629,211,415.36 | 310,953,639.35 |
| 营业成本(元) | 1,106,078,300.23 | 695,125,414.56 | 332,636,926.09 | 1,152,955,895.32 | 800,855,787.02 | 494,095,547.51 | 244,814,225.07 |
| 研发费用(元) | 90,514,239.06 | 63,352,200.84 | 28,484,280.20 | 108,824,394.48 | 77,313,400.23 | 54,351,137.66 | 24,726,169.10 |
| 营业税金及附加(元) | 9,490,869.04 | 5,854,869.36 | 2,655,950.84 | 10,744,013.64 | 8,190,489.38 | 5,466,558.40 | 3,004,350.78 |
| 销售费用(元) | 46,968,066.10 | 31,571,070.71 | 10,871,898.78 | 50,403,621.59 | 35,199,555.72 | 23,913,398.73 | 7,697,747.71 |
| 管理费用(元) | 110,141,858.91 | 66,905,121.43 | 32,352,137.08 | 121,681,216.64 | 88,695,784.32 | 56,594,790.49 | 27,297,615.30 |
| 财务费用(元) | 19,426,386.99 | 7,700,624.00 | 4,602,277.90 | 3,096,886.35 | -3,448,594.55 | -5,210,017.43 | 3,413,531.39 |
| 其中：利息费用(元) | 27,120,928.31 | 16,590,223.23 | 7,443,732.59 | 10,638,219.34 | 5,408,771.08 | 2,134,207.11 | 889,725.79 |
| 其中：利息收入(元) | 2,735,635.59 | 2,080,128.52 | 665,131.47 | 3,048,017.25 | 2,479,420.28 | 1,676,414.94 | 552,206.92 |
| 三、其他经营收益 | |||||||
| 加：公允价值变动收益(元) | - | - | - | -313,237.93 | -309,539.30 | -276,251.63 | 228,490.10 |
| 加：投资收益(元) | 1,043,111.40 | -51,080.29 | - | 2,860,577.78 | 2,777,895.53 | 2,593,081.77 | 1,353,895.07 |
| 其中：对联营企业和合营企业的投资收益(元) | 1,043,111.40 | -51,080.29 | - | - | - | - | - |
| 资产处置收益(元) | -71,933.90 | -66,998.76 | -28,746.05 | -5,224.18 | -17,996.20 | - | -524,294.01 |
| 资产减值损失(元) | -183,649.98 | -183,649.98 | - | -2,942,242.87 | - | - | - |
| 信用减值损失(元) | 472,163.36 | 521,596.53 | 1,205,714.07 | -403,445.47 | -1,001,266.26 | -2,039,307.74 | -942,976.05 |
| 其他收益(元) | 24,805,207.35 | 17,482,098.66 | 5,878,493.79 | 21,144,743.28 | 9,928,167.01 | 5,709,487.89 | 2,582,371.78 |
| 四、营业利润(元) | 182,479,304.25 | 163,413,402.97 | 96,233,364.51 | 510,903,260.37 | 368,732,100.72 | 226,664,202.42 | 91,998,601.34 |
| 加：营业外收入(元) | 2,361,878.04 | 1,209,998.98 | 358,340.42 | 1,591,649.34 | 1,390,817.07 | 580,711.27 | 18,160.19 |
| 减：营业外支出(元) | 730,426.76 | 129,754.15 | 5,771.01 | 6,223,967.51 | 7,442,181.09 | 6,097,797.22 | 267,230.64 |
| 五、利润总额(元) | 184,110,755.53 | 164,493,647.80 | 96,585,933.92 | 506,270,942.20 | 362,680,736.70 | 221,147,116.47 | 91,749,530.89 |
| 减：所得税费用(元) | 16,114,036.83 | 16,501,535.83 | 10,717,330.27 | 59,671,136.02 | 43,281,601.27 | 30,028,418.76 | 10,561,193.76 |
| 六、净利润(元) | 167,996,718.70 | 147,992,111.97 | 85,868,603.65 | 446,599,806.18 | 319,399,135.43 | 191,118,697.71 | 81,188,337.13 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | 167,996,718.70 | 147,992,111.97 | 85,868,603.65 | 446,599,806.18 | 319,399,135.43 | 191,118,697.71 | 81,188,337.13 |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | 169,893,703.83 | 149,707,731.84 | 86,574,111.12 | 449,061,466.72 | 319,949,196.04 | 191,236,644.43 | 81,198,285.24 |
| 少数股东损益(元) | -1,896,985.13 | -1,715,619.87 | -705,507.47 | -2,461,660.54 | -550,060.61 | -117,946.72 | -9,948.11 |
| 扣除非经常性损益后的净利润(元) | 165,632,315.15 | 147,503,721.00 | 85,910,725.23 | 438,093,424.06 | 314,974,051.52 | 189,454,160.74 | 78,316,720.65 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | 0.74 | 0.95 | 0.55 | 2.84 | 2.03 | 1.22 | 0.75 |
| 二、稀释每股收益(元) | 0.74 | 0.95 | 0.55 | 2.84 | 2.03 | 1.22 | 0.75 |
| 八、其他综合收益(元) | -196,251.65 | 88,915.74 | 23,061.82 | 81,725.54 | - | - | - |
| 归属于母公司股东的其他综合收益(元) | -196,251.65 | 88,915.74 | 23,061.82 | 81,725.54 | - | - | - |
| 九、综合收益总额(元) | 167,800,467.05 | 148,081,027.71 | 85,891,665.47 | 446,681,531.72 | 319,399,135.43 | 191,118,697.71 | 81,188,337.13 |
| 归属于母公司所有者的综合收益总额(元) | 169,697,452.18 | 149,796,647.58 | 86,597,172.94 | 449,143,192.26 | 319,949,196.04 | 191,236,644.43 | 81,198,285.24 |
| 归属于少数股东的综合收益总额(元) | -1,896,985.13 | -1,715,619.87 | -705,507.47 | -2,461,660.54 | -550,060.61 | -117,946.72 | -9,948.11 |
| 公告日期 | 2024-10-29 | 2024-08-28 | 2024-04-22 | 2024-04-22 | 2023-10-26 | 2023-08-29 | 2023-04-26 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 其中：对联营企业和合营企业的投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 八、其他综合收益(元) |
| 归属于母公司股东的其他综合收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 44 of 44 entries